Home/Publication/Lilly Asia & Lapam Co-lead to Treat Abnormal Heartbeats
Lilly Asia & Lapam Co-lead to Treat Abnormal Heartbeats 

03 Aug 2023

US$ 19.00

Lilly Asia Ventures and Lapam Capital co-led the Rmb200 million (US$28 million) series A funding round of EnChannel...

Price / article: US$19.00
OR existing subscriber
Related Publications

Granite Asia has led a US$60 m series A funding round in the US-based Centific Global Solutions Inc (Centific), an AI...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.